Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Baratti, Mariana O ^a   Moreira, Yuri B ^b   Traina, Fabiola ^a   Costa, Fernando F ^a   Verjovski Almeida, Sergio ^b   Olalla Saad, Sara T ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10 RECEPTOR ALPHA; LYMPHOID ENHANCER FACTOR 1; PROTEIN ABCB7; PROTEIN AFF1; PROTEIN ASAP2; PROTEIN BLNK; PROTEIN CPSF6; PROTEIN EBF1; PROTEIN ERO1LB; PROTEIN FRAS1; PROTEIN GABPB1; PROTEIN ICA1; PROTEIN IFI30; PROTEIN IGSF10; PROTEIN KHL5; PROTEIN MORN1; PROTEIN NEIL1; PROTEIN NR4A2; PROTEIN NUP153; PROTEIN PAG1; PROTEIN PIAS2; PROTEIN PRG4; PROTEIN SNX20; PROTEIN ST7OT1; PROTEIN TLE1; PROTEIN TNFAIP3; PROTEIN ZNF6; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VASCULOTROPIN; CD34 ANTIGEN; PROTEIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CD34 SELECTION; CELL ADHESION; CELL CYCLE; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPLICATION; DOWN REGULATION; EXOCYTOSIS; EXON; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INTRON; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MICROARRAY ANALYSIS; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MIDDLE AGED; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA;

AGED; ANEMIA, REFRACTORY; ANEMIA, SIDEROBLASTIC; ANTIGENS, CD34; EXONS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; INTRONS; MALE; MIDDLE AGED; PROTEINS; RNA, UNTRANSLATED; STROMAL CELLS;

EID: 77954548906     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-30     Document Type: Article

References (60)

1. Myelodysplastic syndromes. AF List J Vardiman JP Issa TM DeWitte, Hematology Am Soc Hematol Educ Program 2004 297 317 15561689
2. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. GJ Mufti, Best Pract Res Clin Haematol 2004 17 543 557 15494293
3. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. C Aul DT Bowen Y Yoshida, Haematologica 1998 83 71 86 9542325
4. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. M Cazzola R Invernizzi G Bergamaschi S Levi B Corsi E Travaglino V Rolandi G Biasiotto J Drysdale P Arosio, Blood 2003 101 1996 2000 10.1182/blood-2002-07-2006 12406866
5. International scoring system for evaluating prognosis in myelodysplastic syndromes. P Greenberg C Cox MM LeBeau P Fenaux P Morel G Sanz M Sanz T Vallespi T Hamblin D Oscier, et al. Blood 1997 89 2079 2088 9058730
6. Differentially expressed genes in adult familial myelodysplastic syndromes. A Pradhan A Mijovic K Mills P Cumber N Westwood GJ Mufti FV Rassool, Leukemia 2004 18 449 459 10.1038/sj.leu.2403265 14737073
7. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. A Pellagatti M Cazzola AA Giagounidis L Malcovati MG Porta S Killick LJ Campbell L Wang CF Langford C Fidler, et al. Blood 2006 108 337 345 10.1182/blood-2005-12-4769 16527891
8. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. WK Hofmann S de Vos M Komor D Hoelzer W Wachsman HP Koeffler, Blood 2002 100 3553 3560 10.1182/blood.V100.10.3553 12411319
9. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. G Chen W Zeng A Miyazato E Billings JP Maciejewski S Kajigaya EM Sloand NS Young, Blood 2004 104 4210 4218 10.1182/blood-2004-01-0103 15315976
10. Composition and function of the hemopoietic microenvironment in human myeloid leukemia. H Mayani, Leukemia 1996 10 1041 1047 8667639
11. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia. GB Tennant V Walsh LN Truran P Edwards KI Mills AK Burnett, Br J Haematol 2000 111 853 862 10.1046/j.1365-2141.2000.02467.x 11122147
12. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. S Tauro MD Hepburn DT Bowen MJ Pippard, Haematologica 2001 86 1038 1045 11602409
13. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. E Flores-Figueroa G Gutierrez-Espindola JJ Montesinos RM Arana-Trejo H Mayani, Leuk Res 2002 26 677 686 10.1016/S0145-2126(01)00193-X 12008086
14. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. E Birney JA Stamatoyannopoulos A Dutta R Guigo TR Gingeras EH Margulies Z Weng M Snyder ET Dermitzakis RE Thurman, et al. Nature 2007 447 799 816 10.1038/nature05874 17571346
15. A noncoding RNA is a potential marker of cell fate during mammary gland development. MR Ginger AN Shore A Contreras M Rijnkels J Miller MF Gonzalez-Rimbau JM Rosen, Proc Natl Acad Sci USA 2006 103 5781 5786 10.1073/pnas.0600745103 16574773
16. Non-coding-RNA regulators of RNA polymerase II transcription. JA Goodrich JF Kugel, Nat Rev Mol Cell Biol 2006 7 612 616 10.1038/nrm1946 16723972
17. An antisense RNA involved in p53 mRNA maturation in murine erythroleukemia cells induced to differentiate. S Khochbin JJ Lawrence, EMBO J 1989 8 4107 4114 2480234
18. The function of non-coding RNAs in genomic imprinting. MV Koerner FM Pauler R Huang DP Barlow, Development 2009 136 1771 1783 10.1242/dev.030403 19429783
19. Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas. MD Yan CC Hong GM Lai AL Cheng YW Lin SE Chuang, Hum Mol Genet 2005 14 1465 1474 10.1093/hmg/ddi156 15829500
20. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts. GW Krystal BC Armstrong JF Battey, Mol Cell Biol 1990 10 4180 4191 1695323
21. Intronic noncoding RNAs and splicing. JW Brown DF Marshall M Echeverria, Trends Plant Sci 2008 13 335 342 10.1016/j.tplants.2008.04.010 18555733
22. microPrimer: the biogenesis and function of microRNA. T Du PD Zamore, Development 2005 132 4645 4652 10.1242/dev.02070 16224044
23. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. T Kiss, Cell 2002 109 145 148 10.1016/S0092-8674(02)00718-3 12007400
24. Large-scale transcriptional activity in chromosomes 21 and 22. P Kapranov SE Cawley J Drenkow S Bekiranov RL Strausberg SP Fodor TR Gingeras, Science 2002 296 916 919 10.1126/science.1068597 11988577
25. Genome mapping and expression analyses of human intronic noncoding RNAs reveal tissue-specific patterns and enrichment in genes related to regulation of transcription. HI Nakaya PP Amaral R Louro A Lopes AA Fachel YB Moreira TA El-Jundi AM da Silva EM Reis S Verjovski-Almeida, Genome Biol 2007 8 43 10.1186/gb-2007-8-3-r43 17386095
26. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. S Cawley S Bekiranov HH Ng P Kapranov EA Sekinger D Kampa A Piccolboni V Sementchenko J Cheng AJ Williams, et al. Cell 2004 116 499 509 10.1016/S0092-8674(04)00127-8 14980218
27. Androgen responsive intronic non-coding RNAs. R Louro HI Nakaya PP Amaral F Festa MC Sogayar AM da Silva S Verjovski-Almeida EM Reis, BMC Biol 2007 5 4 10.1186/1741-7007-5-4 17263875
28. A new frontier for molecular medicine: noncoding RNAs. M Szymanski MZ Barciszewska VA Erdmann J Barciszewski, Biochim Biophys Acta 2005 1756 65 75 16125325
29. Studying chromosome-wide transcriptional networks: new insights into disease? P Kapranov, Genome Med 2009 1 50 10.1186/gm50 19480644
30. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. C Tufarelli JA Stanley D Garrick JA Sharpe H Ayyub WG Wood DR Higgs, Nat Genet 2003 34 157 165 10.1038/ng1157 12730694
31. Non-coding RNAs in imprinted gene clusters. H Royo J Cavaille, Biol Cell 2008 100 149 166 10.1042/BC20070126 18271756
32. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. W Yu D Gius P Onyango K Muldoon-Jacobs J Karp AP Feinberg H Cui, Nature 2008 451 202 206 10.1038/nature06468 18185590
33. Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. EM Reis HI Nakaya R Louro FC Canavez AV Flatschart GT Almeida CM Egidio AC Paquola AA Machado F Festa, et al. Oncogene 2004 23 6684 6692 10.1038/sj.onc.1207880 15221013
34. Long, abundantly expressed non-coding transcripts are altered in cancer. DS Perez TR Hoage JR Pritchett AL Ducharme-Smith ML Halling SC Ganapathiraju PS Streng DI Smith, Hum Mol Genet 2008 17 642 655 10.1093/hmg/ddm336 18006640
35. Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma. GC Brito AA Fachel AL Vettore GM Vignal ER Gimba FS Campos MA Barcinski S Verjovski-Almeida EM Reis, Mol Carcinog 2008 47 757 767 10.1002/mc.20433 18348187
36. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. X Zhang Z Lian C Padden MB Gerstein J Rozowsky M Snyder TR Gingeras P Kapranov SM Weissman PE Newburger, Blood 2009 113 2526 2534 10.1182/blood-2008-06-162164 19144990
37. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. TR Hughes M Mao AR Jones J Burchard MJ Marton KW Shannon SM Lefkowitz M Ziman JM Schelter MR Meyer, et al. Nat Biotechnol 2001 19 342 347 10.1038/86730 11283592
38. RNAdb - a comprehensive mammalian noncoding RNA database. KC Pang S Stephen PG Engstrom K Tajul-Arifin W Chen C Wahlestedt B Lenhard Y Hayashizaki JS Mattick, Nucleic Acids Res 2005 33 125 130 10.1093/nar/gki089 15608161
39. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. BM Bolstad RA Irizarry M Astrand TP Speed, Bioinformatics 2003 19 185 193 10.1093/bioinformatics/19.2.185 12538238
40. Significance analysis of microarrays applied to the ionizing radiation response. VG Tusher R Tibshirani G Chu, Proc Natl Acad Sci USA 2001 98 5116 5121 10.1073/pnas.091062498 11309499
41. Gene expression profiling predicts clinical outcome of breast cancer. LJ van 't Veer H Dai MJ van de Vijver YD He AA Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen, et al. Nature 2002 415 530 536 10.1038/415530a 11823860
42. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. KJ Livak TD Schmittgen, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609
43. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. J Boultwood A Pellagatti M Nikpour B Pushkaran C Fidler H Cattan TJ Littlewood L Malcovati MG Della Porta M Jadersten, et al. PLoS ONE 2008 3 1970 10.1371/journal.pone.0001970 18398482
44. DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome. M Ueda J Ota Y Yamashita YL Choi R Ohki T Wada K Koinuma Y Kano K Ozawa H Mano, Br J Haematol 2003 123 288 296 10.1046/j.1365-2141.2003.04601.x 14531911 (Pubitemid 37305064)
45. Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. W Zeng A Miyazato G Chen S Kajigaya NS Young JP Maciejewski, Blood 2006 107 167 175 10.1182/blood-2005-05- 1884 16131564
46. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. M Voulgarelis S Giannouli K Ritis AG Tzioufas, Eur J Clin Invest 2004 34 690 700 10.1111/j.1365-2362.2004.01417.x 15473894
47. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. P Gupta TR Oegema JJ Brazil AZ Dudek A Slungaard CM Verfaillie, Blood 1998 92 4641 4651 9845530
48. Lingering biologic dilemmas about the status of the progenitor cells in myelodysplasia. SD Mundle, Arch Med Res 2003 34 515 519 10.1016/j.arcmed.2003. 09.001 14734091
49. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. A Sternberg S Killick T Littlewood C Hatton A Peniket T Seidl S Soneji J Leach D Bowen C Chapman, et al. Blood 2005 106 2982 2991 10.1182/blood-2005-04-1543 16076868
50. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. JM Ramirez O Schaad S Durual D Cossali M Docquier P Beris P Descombes T Matthes, Br J Haematol 2009 144 251 262 10.1111/j.1365-2141.2008. 07441.x 19036111
51. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. JE Parker GJ Mufti F Rasool A Mijovic S Devereux A Pagliuca, Blood 2000 96 3932 3938 11090080
52. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia. M Kitagawa S Yamaguchi M Takahashi T Tanizawa K Hirokawa R Kamiyama, Leukemia 1998 12 486 492 10.1038/sj.leu.2400980 9557605
53. Signalling by semaphorin receptors: cell guidance and beyond. L Tamagnone PM Comoglio, Trends Cell Biol 2000 10 377 383 10.1016/S0962-8924(00)01816-X 10932095
54. Invasive growth: a two-way street for semaphorin signalling. PM Comoglio L Tamagnone S Giordano, Nat Cell Biol 2004 6 1155 1157 10.1038/ncb1204-1155 15573094
55. Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. S Moretti A Procopio R Lazzarini MR Rippo R Testa M Marra L Tamagnone A Catalano, Blood 2008 111 2290 2299 10.1182/blood-2007-06-096529 18056484
56. Differential MAP kinases activation during semaphorin3A-induced repulsion or apoptosis of neural progenitor cells. D Bagnard N Sainturet D Meyronet M Perraut M Miehe G Roussel D Aunis MF Belin N Thomasset, Mol Cell Neurosci 2004 25 722 731 10.1016/j.mcn.2003.12.007 15080899
57. Conserved tissue expression signatures of intronic noncoding RNAs transcribed from human and mouse loci. R Louro T El-Jundi HI Nakaya EM Reis S Verjovski-Almeida, Genomics 2008 92 18 25 10.1016/j.ygeno.2008.03.013 18495418
58. EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. LA Wagner CJ Christensen DM Dunn GJ Spangrude A Georgelas L Kelley MS Esplin RB Weiss GJ Gleich, Blood 2007 109 5191 5198 10.1182/blood-2006-06-027987 17351112
59. Long intronic noncoding RNA transcription: expression noise or expression choice? R Louro AS Smirnova S Verjovski-Almeida, Genomics 2009 93 291 298 10.1016/j.ygeno.2008.11.009 19071207
60. NR4A nuclear orphan receptors: protective in vascular disease? TW Pols PI Bonta CJ de Vries, Curr Opin Lipidol 2007 18 515 520 10.1097/MOL. 0b013e3282ef77d1 17885421